[1] Guo F,Kuo YF,Shih YCT,et al.Trends in breast cancer mortality by stage at diagnosis among young women in the United States[J]. Cancer,2018,124:3500-3509. [2] Lu TX, Rothenberg ME. MicroRNA[J].J Allergy Clin Immunol,2018,141:1202-1207. [3] Zhang J,Luo N,Luo Y,et al.MicroRNA-150 inhibits human CDl33-positive liver cancer stem cells through negative regulation of the trail—scription factor c-Myb[J]. Int J Oncol,2012,40:747-756. [4] Leblanc N,Harquail J,Crapoulet N,et al.Pax-5 inhibits breast cancer proliferation though miR-215 up-regulation[J]. Anticancer Res,2018,38:5013-5026. [5] Li L,Jia L,Ding Y.Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2[J].Oncol Lett,2018,16:3319-3326. [6] Yang H,Zhang H,Ge S,et al.Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells[J].Mol Ther,2018,26:2466-2475. [7] 刘洋,董毅龙.miRNA在乳腺癌中作用的研究进展[J].实用肿瘤杂志,2017,32:300-303. [8] 王燕,于洋,李擎,等.miRNA-29在正常乳腺、原发性乳腺癌及转移性乳腺癌组织中的表达意义[J].实用癌症杂志,2016,31:1763-1766. [9] 李芳,翟从劼,田延锋,等.miRNA-214在乳腺癌组织中的表达及其意义[J].中国肿瘤,2016,25:816-819. [10] 程学远,黄忠.miR-320在乳腺癌组织中的表达及临床意义[J].中国现代医学杂志,2017,27:58-61. [11] Simonson B,Das S. MicroRNA therapeutics: the next magic bullet[J].Mini Rev Med Chem,2015,15:467-474. [12] Little CD,Nau MM,Carney DN,et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines[J]. Nature,1983,306:194-196. [13] Chi VD,Kathryn AOD,Karen IZ, et al. The c-Myc target gene network [J].Semin Cancer Biol,2006,16:253-264. [14] Trop-Steinberg S,Azar Y.Is Myc an important biomarker? Myc expression in immune disorders and cancer[J].AJMS,2018.355:67-75. |